Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher E. Berndsen is active.

Publication


Featured researches published by Christopher E. Berndsen.


Nature Structural & Molecular Biology | 2014

New insights into ubiquitin E3 ligase mechanism.

Christopher E. Berndsen; Cynthia Wolberger

E3 ligases carry out the final step in the ubiquitination cascade, catalyzing transfer of ubiquitin from an E2 enzyme to form a covalent bond with a substrate lysine. Three distinct classes of E3 ligases have been identified that stimulate transfer of ubiquitin and ubiquitin-like proteins through either a direct or an indirect mechanism. Only recently have the catalytic mechanisms of E3 ligases begun to be elucidated.


Science | 2010

Structural Insights into the Assembly and Function of the SAGA Deubiquitinating Module

Nadine L. Samara; Ajit B. Datta; Christopher E. Berndsen; Xiangbin Zhang; Tingting Yao; Robert E. Cohen; Cynthia Wolberger

Complex SAGA The SAGA (Spt-Ada-Gcn5-Acetyltransferase) complex, which is conserved in eukaryotes, plays a key role in regulating gene expression. It is comprised of 21 proteins, and its functions include histone acetylation and deubiquitination. Samara et al. (p. 1025, published online 15 April) now report the structure of the SAGA deubiquitinating module (DUBm), a four-protein subcomplex, both on its own and bound to ubiquitin aldehyde. The domains are interconnected and stabilized by eight zinc atoms. The organization gives insight into why DUBm complex formation is required to activate the catalytic domain of the enzyme and suggests how DUBm might bind to monoubiquitinated histones. Structures give insight into how a regulator of eukaryotic gene expression achieves one of its chromatin-modifying functions. SAGA is a transcriptional coactivator complex that is conserved across eukaryotes and performs multiple functions during transcriptional activation and elongation. One role is deubiquitination of histone H2B, and this activity resides in a distinct subcomplex called the deubiquitinating module (DUBm), which contains the ubiquitin-specific protease Ubp8, bound to Sgf11, Sus1, and Sgf73. The deubiquitinating activity depends on the presence of all four DUBm proteins. We report here the 1.90 angstrom resolution crystal structure of the DUBm bound to ubiquitin aldehyde, as well as the 2.45 angstrom resolution structure of the uncomplexed DUBm. The structure reveals an arrangement of protein domains that gives rise to a highly interconnected complex, which is stabilized by eight structural zinc atoms that are critical for enzymatic activity. The structure suggests a model for how interactions with the other DUBm proteins activate Ubp8 and allows us to speculate about how the DUBm binds to monoubiquitinated histone H2B in nucleosomes.


Science Signaling | 2012

RNF4-Dependent Hybrid SUMO-Ubiquitin Chains are Signals for RAP80 and thereby Mediate the Recruitment of BRCA1 to Sites of DNA Damage

Catherine M. Guzzo; Christopher E. Berndsen; Jianmei Zhu; Vibhor Gupta; Ajit B. Datta; Roger A. Greenberg; Cynthia Wolberger; Michael J. Matunis

DNA repair proteins find sites of damage marked by hybrid SUMO-ubiquitin chains. Hybrid Chains Mark the Spot Posttranslational modifications play a key role in marking sites of DNA damage so that the DNA repair machinery can find the damaged area and effect repair. Guzzo et al. report a role for hybrid chains consisting of SUMO attached to a Lys63-linked diubiquitin as contributing to the recruitment of the protein RAP80, which in turn recruits the DNA repair protein BRCA1, to sites of damaged DNA. Knockdown of the E3 ligase RNF4, which synthesizes hybrid SUMO-ubiquitin linkages, prevented efficient recruitment of RAP80 and BRCA1 to sites of DNA damage induced by irradiation. This study defined a high-affinity interaction between a closely positioned pair of ubiquitin-interacting motifs and a SUMO-interacting motif in RAP80 that contributes to the recognition of sites of DNA damage. The DNA repair function of the breast cancer susceptibility protein BRCA1 depends in part on its interaction with RAP80, which targets BRCA1 to DNA double-strand breaks (DSBs) through recognition of K63-linked polyubiquitin chains. The localization of BRCA1 to DSBs also requires sumoylation. We demonstrated that, in addition to having ubiquitin-interacting motifs, RAP80 also contains a SUMO-interacting motif (SIM) that is critical for recruitment to DSBs. In combination with the ubiquitin-binding activity of RAP80, this SIM enabled RAP80 to bind with nanomolar affinity to hybrid chains consisting of ubiquitin conjugated to SUMO. Furthermore, RNF4, a SUMO-targeted ubiquitin E3 ligase that synthesizes hybrid SUMO-ubiquitin chains, localized to DSBs and was critical for the recruitment of RAP80 and BRCA1 to sites of DNA damage. Our findings, therefore, connect ubiquitin- and SUMO-dependent DSB recognition, revealing that RNF4-synthesized hybrid SUMO-ubiquitin chains are recognized by RAP80 to promote BRCA1 recruitment and DNA repair.


Journal of Biological Chemistry | 2013

Architectural Organization of the Metabolic Regulatory Enzyme Ghrelin O-Acyltransferase

Martin S. Taylor; Travis R. Ruch; Po Yuan Hsiao; Yousang Hwang; Pingfeng Zhang; Lixin Dai; Cheng Ran Lisa Huang; Christopher E. Berndsen; Min Sik Kim; Akhilesh Pandey; Cynthia Wolberger; Ronen Marmorstein; Carolyn E. Machamer; Jef D. Boeke; Philip A. Cole

Background: Ghrelin O-acyltransferase (GOAT) is a membrane protein that is responsible for octanoylating the metabolism-regulating peptide hormone ghrelin. Results: We have used a combination of approaches to determine the topology of GOAT. Conclusion: We have shown that GOAT has 11 transmembrane-spanning domains and one reentrant loop. Significance: These findings serve as a reference for other membrane-bound O-acyltransferase family members. Ghrelin O-acyltransferase (GOAT) is a polytopic integral membrane protein required for activation of ghrelin, a secreted metabolism-regulating peptide hormone. Although GOAT is a potential therapeutic target for the treatment of obesity and diabetes and plays a key role in other physiologic processes, little is known about its structure or mechanism. GOAT is a member of the membrane-bound O-acyltransferase (MBOAT) family, a group of polytopic integral membrane proteins involved in lipid-biosynthetic and lipid-signaling reactions from prokaryotes to humans. Here we use phylogeny and a variety of bioinformatic tools to predict the topology of GOAT. Using selective permeabilization indirect immunofluorescence microscopy in combination with glycosylation shift immunoblotting, we demonstrate that GOAT contains 11 transmembrane helices and one reentrant loop. Development of the V5Glyc tag, a novel, small, and sensitive dual topology reporter, facilitated these experiments. The MBOAT family invariant residue His-338 is in the ER lumen, consistent with other family members, but conserved Asn-307 is cytosolic, making it unlikely that both are involved in catalysis. Photocross-linking of synthetic ghrelin analogs and inhibitors demonstrates binding to the C-terminal region of GOAT, consistent with a role of His-338 in the active site. This knowledge of GOAT architecture is important for a deeper understanding of the mechanism of GOAT and other MBOATs and could ultimately advance the discovery of selective inhibitors for these enzymes.


Analytical Biochemistry | 2011

A spectrophotometric assay for conjugation of ubiquitin and ubiquitin-like proteins

Christopher E. Berndsen; Cynthia Wolberger

Ubiquitination is a widely studied regulatory modification involved in protein degradation, DNA damage repair, and the immune response. Ubiquitin is conjugated to a substrate lysine in an enzymatic cascade involving an E1 ubiquitin-activating enzyme, an E2 ubiquitin-conjugating enzyme, and an E3 ubiquitin ligase. Assays for ubiquitin conjugation include electrophoretic mobility shift assays and detection of epitope-tagged or radiolabeled ubiquitin, which are difficult to quantitate accurately and are not amenable to high-throughput screening. We have developed a colorimetric assay that quantifies ubiquitin conjugation by monitoring pyrophosphate released in the first enzymatic step in ubiquitin transfer, the ATP-dependent charging of the E1 enzyme. The assay is rapid, does not rely on radioactive labeling, and requires only a spectrophotometer for detection of pyrophosphate formation. We show that pyrophosphate production by E1 is dependent on ubiquitin transfer and describe how to optimize assay conditions to measure E1, E2, and E3 activity. The kinetics of polyubiquitin chain formation by Ubc13-Mms2 measured by this assay are similar to those determined by gel-based assays, indicating that the data produced by this method are comparable to methods that measure ubiquitin transfer directly. This assay is adaptable to high-throughput screening of ubiquitin and ubiquitin-like conjugating enzymes.


Nature Chemical Biology | 2013

A conserved asparagine has a structural role in ubiquitin-conjugating enzymes

Christopher E. Berndsen; Reuven Wiener; Ian W. Yu; Alison E. Ringel; Cynthia Wolberger

It is widely accepted that ubiquitin conjugating enzymes (E2) contain an active site asparagine that serves as an oxyanion hole, thereby stabilizing a negatively charged transition state intermediate and promoting ubiquitin transfer. Using structural and biochemical approaches to study the role of the conserved asparagine to ubiquitin conjugation by Ubc13/Mms2, we conclude that the importance of this residue stems primarily from its structural role in stabilizing an active site loop.


Cell Reports | 2016

Trans-Binding Mechanism of Ubiquitin-like Protein Activation Revealed by a UBA5-UFM1 Complex

Walaa Oweis; Prasanth Padala; Fouad Hassouna; Einav Cohen-Kfir; Dalton R. Gibbs; Emily A. Todd; Christopher E. Berndsen; Reuven Wiener

Modification of proteins by ubiquitin or ubiquitin-like proteins (UBLs) is a critical cellular process implicated in a variety of cellular states and outcomes. A prerequisite for target protein modification by a UBL is the activation of the latter by activating enzymes (E1s). Here, we present the crystal structure of the non-canonical homodimeric E1, UBA5, in complex with its cognate UBL, UFM1, and supporting biochemical experiments. We find that UBA5 binds to UFM1 via a trans-binding mechanism in which UFM1 interacts with distinct sites in both subunits of the UBA5 dimer. This binding mechanism requires a region C-terminal to the adenylation domain that brings UFM1 to the active site of the adjacent UBA5 subunit. We also find that transfer of UFM1 from UBA5 to the E2, UFC1, occurs via a trans mechanism, thereby requiring a homodimer of UBA5. These findings explicitly elucidate the role of UBA5 dimerization in UFM1 activation.


Journal of Biological Chemistry | 2012

The Size and Conservation of a Coiled-coil Structure in the Ectodomain of Human BST-2/Tetherin Is Dispensable for Inhibition of HIV-1 Virion Release

Amy J. Andrew; Christopher E. Berndsen; Sandra Kao; Klaus Strebel

Background: BST-2 inhibits virus release by tethering virions to the cell surface. Results: The length of the BST-2 ectodomain can be increased or reduced without loss of function. Conclusion: The positioning of ectodomain deletions rather than their size determines the impact on BST-2 function. Significance: Understanding the importance of structural elements in BST-2 is critical for developing antiviral strategies. BST-2/CD317/tetherin is a host factor that inhibits HIV-1 release and is counteracted by HIV-1 Vpu. Structural studies indicate that the BST-2 ectodomain assumes a coiled-coil conformation. Here we studied the role of the BST-2 ectodomain for tethering function. First, we addressed the importance of the length and structure of the ectodomain by adding or substituting heterologous coiled-coil or non-coiled-coil sequences. We found that extending or replacing the BST-2 ectodomain using non-coiled-coil sequences resulted in loss of BST-2 function. Doubling the size of the BST-2 ectodomain by insertion of a heterologous coiled-coil motif or substituting the BST-2 coiled-coil domain with a heterologous coiled-coil motif maintained tethering function. Reductions in the size of the BST-2 coiled-coil domain were tolerated as well. In fact, deletion of the C-terminal half of the BST-2 ectodomain, including a series of seven consecutive heptad motifs did not abolish tethering function. However, slight changes in the positioning of deletions affecting the relative placing of charged or hydrophobic residues on the helix severely impacted the functional properties of BST-2. Overall, we conclude that the size of the BST-2 ectodomain is highly flexible and can be reduced or extended as long as the positioning of residues important for the stability of the dimer interface is maintained.


Journal of Molecular and Cellular Cardiology | 2017

Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway

Maegen A. Ackermann; Brendan King; Nicole A.P. Lieberman; Prameela Jyothi Bobbili; Michael W. Rudloff; Christopher E. Berndsen; Nathan T. Wright; Peter A. Hecker; Aikaterini Kontrogianni-Konstantopoulos

The intercalated disc of cardiac muscle embodies a highly-ordered, multifunctional network, essential for the synchronous contraction of the heart. Over 200 known proteins localize to the intercalated disc. The challenge now lies in their characterization as it relates to the coupling of neighboring cells and whole heart function. Using molecular, biochemical and imaging techniques, we characterized for the first time two small obscurin isoforms, obscurin-40 and obscurin-80, which are enriched at distinct locations of the intercalated disc. Both proteins bind specifically and directly to select phospholipids via their pleckstrin homology (PH) domain. Overexpression of either isoform or the PH-domain in cardiomyocytes results in decreased cell adhesion and size via reduced activation of the PI3K/AKT/mTOR pathway that is intimately linked to cardiac hypertrophy. In addition, obscurin-80 and obscurin-40 are significantly reduced in acute (myocardial infarction) and chronic (pressure overload) murine cardiac-stress models underscoring their key role in maintaining cardiac homeostasis. Our novel findings implicate small obscurins in the maintenance of cardiomyocyte size and coupling, and the development of heart failure by antagonizing the PI3K/AKT/mTOR pathway.


Science Advances | 2017

Deregulated Ca2+ cycling underlies the development of arrhythmia and heart disease due to mutant obscurin

Li-Yen R. Hu; Maegen A. Ackermann; Peter A. Hecker; Benjamin L. Prosser; Brendan King; Kelly A. O’Connell; Alyssa Grogan; Logan C. Meyer; Christopher E. Berndsen; Nathan T. Wright; W. Jonathan Lederer; Aikaterini Kontrogianni-Konstantopoulos

The goal of this study is to understand how a particular mutation in obscurin proteins leads to congenital heart disease. Obscurins are cytoskeletal proteins with structural and regulatory roles encoded by OBSCN. Mutations in OBSCN are associated with the development of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Specifically, the R4344Q mutation present in immunoglobulin domain 58 (Ig58) was the first to be linked with the development of HCM. To assess the effects of R4344Q in vivo, we generated the respective knock-in mouse model. Mutant obscurins are expressed and incorporated normally into sarcomeres. The expression patterns of sarcomeric and Ca2+-cycling proteins are unaltered in sedentary 1-year-old knock-in myocardia, with the exception of sarco/endoplasmic reticulum Ca2+ adenosine triphosphatase 2 (SERCA2) and pentameric phospholamban whose levels are significantly increased and decreased, respectively. Isolated cardiomyocytes from 1-year-old knock-in hearts exhibit increased Ca2+-transients and Ca2+-load in the sarcoplasmic reticulum and faster contractility kinetics. Moreover, sedentary 1-year-old knock-in animals develop tachycardia accompanied by premature ventricular contractions, whereas 2-month-old knock-in animals subjected to pressure overload develop a DCM-like phenotype. Structural analysis revealed that the R4344Q mutation alters the distribution of electrostatic charges over the Ig58 surface, thus interfering with its binding capabilities. Consistent with this, wild-type Ig58 interacts with phospholamban modestly, and this interaction is markedly enhanced in the presence of R4344Q. Together, our studies demonstrate that under sedentary conditions, the R4344Q mutation results in Ca2+ deregulation and spontaneous arrhythmia, whereas in the presence of chronic, pathological stress, it leads to cardiac remodeling and dilation. We postulate that enhanced binding between mutant obscurins and phospholamban leads to SERCA2 disinhibition, which may underlie the observed pathological alterations.

Collaboration


Dive into the Christopher E. Berndsen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cynthia Wolberger

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Emily A. Todd

James Madison University

View shared research outputs
Top Co-Authors

Avatar

Reuven Wiener

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Einav Cohen-Kfir

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Prasanth Padala

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Walaa Oweis

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge